{"id":344658,"date":"2025-08-24T13:40:01","date_gmt":"2025-08-24T13:40:01","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-biohaven\/"},"modified":"2025-08-24T13:40:01","modified_gmt":"2025-08-24T13:40:01","slug":"how-to-buy-biohaven","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/","title":{"rendered":"How to buy Biohaven Ltd. (BHVN) shares &#8211; Investment in Biohaven Ltd. (BHVN) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-344658","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Biohaven Ltd. (BHVN) Shares - Investment in Biohaven Ltd. (BHVN) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Biohaven Ltd. (BHVN) Shares - Investment in Biohaven Ltd. (BHVN) Stock"},"description":"Learn how to buy Biohaven Ltd. (BHVN) shares and invest in this neuroscience biotech stock. Discover current price, trends, and expert analysis for smart investing decisions.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Biohaven Ltd. (BHVN) shares and invest in this neuroscience biotech stock. Discover current price, trends, and expert analysis for smart investing decisions."},"intro":"Thinking about investing in cutting-edge neuroscience? Biohaven Ltd. (BHVN) represents the frontier of biotech innovation\u2014developing breakthrough treatments for Parkinson's, migraine, and neurological disorders. This company could be your gateway to the future of medicine, but smart investing requires understanding both the science and the stock dynamics. Let's explore everything you need to know about adding BHVN to your portfolio.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in cutting-edge neuroscience? Biohaven Ltd. (BHVN) represents the frontier of biotech innovation\u2014developing breakthrough treatments for Parkinson's, migraine, and neurological disorders. This company could be your gateway to the future of medicine, but smart investing requires understanding both the science and the stock dynamics. Let's explore everything you need to know about adding BHVN to your portfolio."},"body_html":"<h2>\ud83d\udcc8 Biohaven Stock: Current Price and Critical Dates<\/h2> <p>As of August 24, 2025, Biohaven Ltd. (BHVN) trades at <strong>$14.68<\/strong> on the NYSE. Mark your calendar: <strong>November 11, 2025<\/strong> is absolutely critical\u2014that's when Biohaven releases its Q3 earnings report. Historically, these quarterly announcements have triggered significant price movements.<\/p> <h3>How Earnings Reports Move BHVN Stock<\/h3> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 11, 2025<\/td><td>Q2 Earnings<\/td><td>$15.29<\/td><td>-4.0% (1 week)<\/td><\/tr> <tr><td>May 29, 2025<\/td><td>Parkinson's Trial Start<\/td><td>$16.50<\/td><td>+8.2% (3 days)<\/td><\/tr> <tr><td>Feb 12, 2025<\/td><td>Q1 Earnings<\/td><td>$18.20<\/td><td>-12.1% (missed targets)<\/td><\/tr> <tr><td>Nov 5, 2024<\/td><td>Clinical Data Release<\/td><td>$22.40<\/td><td>+6.3% (positive results)<\/td><\/tr> <tr><td>Aug 9, 2024<\/td><td>Q2 Earnings<\/td><td>$25.10<\/td><td>-8.9% (regulatory concerns)<\/td><\/tr> <tr><td>May 15, 2024<\/td><td>FDA Submission<\/td><td>$28.60<\/td><td>+15.2% (investor optimism)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Positive clinical trial news (like May 2025) typically boosts prices significantly, while earnings misses cause sharp declines. The stock shows extreme sensitivity to regulatory developments and trial results.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey (February-August 2025)<\/h2> <p>Biohaven shares have experienced dramatic volatility, declining approximately <strong>42%<\/strong> during this period:<\/p> <p><strong>February<\/strong>: $25.40 (post-Q1 earnings optimism)<br> <strong>March<\/strong>: $21.80 (FDA concerns emerged)<br> <strong>May<\/strong>: $18.90 (Parkinson's trial announcement provided support)<br> <strong>July<\/strong>: $16.20 (summer trading lull)<br> <strong>August<\/strong>: $14.68 (current levels after Q2 results)<\/p> <p><strong>Why the decline?<\/strong><\/p> <ul> <li>Regulatory uncertainty around drug approvals<\/li> <li>High cash burn rate typical of clinical-stage biotech<\/li> <li>Market rotation away from speculative biotech stocks<\/li> <li>Previous FDA setbacks creating investor caution<\/li> <\/ul> <p>However, recent momentum shows signs of stabilization with the Parkinson's trial progress providing fundamental support.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030<\/h2> <p><strong>2025 (Year-End)<\/strong>: $18-22 (potential positive clinical data) \u2192 <strong>BUY for long-term<\/strong><br> <strong>2026<\/strong>: $26-32 (Parkinson's trial Phase 2 results expected)<br> <strong>2028<\/strong>: $45-60 (potential first commercial approval from pipeline)<br> <strong>2030<\/strong>: $75-100+ (multiple approved therapies driving revenue)<\/p> <p><strong>Verdict<\/strong>: Ideal for <strong>risk-tolerant long-term investors<\/strong>. Current prices represent potential entry points before major catalysts.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Clinical trial failures<\/strong>: 90% of drugs fail in late-stage trials<\/li> <li><strong>Regulatory rejection<\/strong>: FDA decisions can instantly wipe out 50%+ of value<\/li> <li><strong>Cash burn<\/strong>: $408.2 million cash reserves (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-reports-second-quarter-2025-financial-results-and-recent-business-developments-302526204.html\">Q2 2025 Report<\/a>) may need replenishment<\/li> <li><strong>High volatility<\/strong>: 9.46% volatility rating with beta of 1.49<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Parkinson's breakthrough<\/strong>: First patient enrolled in Phase 2\/3 trial (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-enrolls-first-patient-into-phase-23-trial-in-early-parkinsons-disease-targeting-neuroinflammation-with-novel-brain-penetrant-tyk2jak1-inhibitor-302467788.html\">May 2025<\/a>)<\/li> <li><strong>Strong analyst support<\/strong>: 13 analysts with \"Strong Buy\" rating, average target $54.62<\/li> <li><strong>Innovative pipeline<\/strong>: Multiple platforms including Kv7 modulation and TYK2\/JAK1 inhibition<\/li> <li><strong>Proven track record<\/strong>: Success with Nurtec ODT migraine treatment<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong>: Allocate no more than 3-5% of your portfolio to high-risk biotech stocks<\/li> <li><strong>Dollar-cost average<\/strong>: Buy in small increments over several months to reduce timing risk<\/li> <li><strong>Set price alerts<\/strong>: Monitor around November 11 earnings for potential entry points<\/li> <li><strong>Diversify<\/strong>: Balance with stable dividend stocks and index funds<\/li> <\/ol> <p>Humorous take: \"Trading BHVN is like watching clinical trials\u2014you need strong nerves and should never bet the house on Phase 1 results!\"<\/p> <h2>\u2705 How to Buy Biohaven Ltd. (BHVN) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NYSE-listed stocks and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with an amount you're comfortable potentially losing<\/td><\/tr> <tr><td>3<\/td><td>Search \"BHVN\"<\/td><td>Use the exact ticker symbol for accurate results<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Use limit orders to control entry price in volatile stocks<\/td><\/tr> <tr><td>5<\/td><td>Review and confirm<\/td><td>Check commission fees\u2014aim for less than 1% of trade value<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>Pocket Option makes stock investing accessible for beginners:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong>\u2014perfect for testing strategies with real money but minimal risk<\/li> <li><strong>Lightning-fast verification<\/strong>\u2014start trading with just one ID document in minutes<\/li> <li><strong>Diverse withdrawal options<\/strong>\u2014access your profits through multiple convenient methods<\/li> <li><strong>Educational resources<\/strong>\u2014learn while you trade with the comprehensive Pocket Option blog<\/li> <\/ul> <h2>\ud83c\udf0d Biohaven in 2025: Neuroscience Innovation Leader<\/h2> <p>Biohaven dominates the neuroscience biotech space with one of the industry's most innovative portfolios. Beyond their proven migraine treatments Nurtec ODT and Zavzpret, they're pioneering breakthrough therapies for Parkinson's, neuroinflammation, and rare neurological disorders. The company presented <strong>13 research abstracts<\/strong> at the 2025 American Academy of Neurology meeting, showcasing their scientific depth across multiple cutting-edge platforms including Kv7 modulation, extracellular protein degradation, and TRPM3 antagonism.<\/p> <p><strong>Interesting Fact<\/strong>: Biohaven's Parkinson's trial represents the first clinical study targeting neuroinflammation with a brain-penetrant TYK2\/JAK1 inhibitor\u2014a completely novel approach that could revolutionize treatment for over 10 million patients worldwide.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Biohaven Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 24, 2025, Biohaven Ltd. (BHVN) trades at <strong>$14.68<\/strong> on the NYSE. Mark your calendar: <strong>November 11, 2025<\/strong> is absolutely critical\u2014that&#8217;s when Biohaven releases its Q3 earnings report. Historically, these quarterly announcements have triggered significant price movements.<\/p>\n<h3>How Earnings Reports Move BHVN Stock<\/h3>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 11, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$15.29<\/td>\n<td>-4.0% (1 week)<\/td>\n<\/tr>\n<tr>\n<td>May 29, 2025<\/td>\n<td>Parkinson&#8217;s Trial Start<\/td>\n<td>$16.50<\/td>\n<td>+8.2% (3 days)<\/td>\n<\/tr>\n<tr>\n<td>Feb 12, 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>$18.20<\/td>\n<td>-12.1% (missed targets)<\/td>\n<\/tr>\n<tr>\n<td>Nov 5, 2024<\/td>\n<td>Clinical Data Release<\/td>\n<td>$22.40<\/td>\n<td>+6.3% (positive results)<\/td>\n<\/tr>\n<tr>\n<td>Aug 9, 2024<\/td>\n<td>Q2 Earnings<\/td>\n<td>$25.10<\/td>\n<td>-8.9% (regulatory concerns)<\/td>\n<\/tr>\n<tr>\n<td>May 15, 2024<\/td>\n<td>FDA Submission<\/td>\n<td>$28.60<\/td>\n<td>+15.2% (investor optimism)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Positive clinical trial news (like May 2025) typically boosts prices significantly, while earnings misses cause sharp declines. The stock shows extreme sensitivity to regulatory developments and trial results.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey (February-August 2025)<\/h2>\n<p>Biohaven shares have experienced dramatic volatility, declining approximately <strong>42%<\/strong> during this period:<\/p>\n<p><strong>February<\/strong>: $25.40 (post-Q1 earnings optimism)<br \/> <strong>March<\/strong>: $21.80 (FDA concerns emerged)<br \/> <strong>May<\/strong>: $18.90 (Parkinson&#8217;s trial announcement provided support)<br \/> <strong>July<\/strong>: $16.20 (summer trading lull)<br \/> <strong>August<\/strong>: $14.68 (current levels after Q2 results)<\/p>\n<p><strong>Why the decline?<\/strong><\/p>\n<ul>\n<li>Regulatory uncertainty around drug approvals<\/li>\n<li>High cash burn rate typical of clinical-stage biotech<\/li>\n<li>Market rotation away from speculative biotech stocks<\/li>\n<li>Previous FDA setbacks creating investor caution<\/li>\n<\/ul>\n<p>However, recent momentum shows signs of stabilization with the Parkinson&#8217;s trial progress providing fundamental support.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030<\/h2>\n<p><strong>2025 (Year-End)<\/strong>: $18-22 (potential positive clinical data) \u2192 <strong>BUY for long-term<\/strong><br \/> <strong>2026<\/strong>: $26-32 (Parkinson&#8217;s trial Phase 2 results expected)<br \/> <strong>2028<\/strong>: $45-60 (potential first commercial approval from pipeline)<br \/> <strong>2030<\/strong>: $75-100+ (multiple approved therapies driving revenue)<\/p>\n<p><strong>Verdict<\/strong>: Ideal for <strong>risk-tolerant long-term investors<\/strong>. Current prices represent potential entry points before major catalysts.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Clinical trial failures<\/strong>: 90% of drugs fail in late-stage trials<\/li>\n<li><strong>Regulatory rejection<\/strong>: FDA decisions can instantly wipe out 50%+ of value<\/li>\n<li><strong>Cash burn<\/strong>: $408.2 million cash reserves (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-reports-second-quarter-2025-financial-results-and-recent-business-developments-302526204.html\">Q2 2025 Report<\/a>) may need replenishment<\/li>\n<li><strong>High volatility<\/strong>: 9.46% volatility rating with beta of 1.49<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Parkinson&#8217;s breakthrough<\/strong>: First patient enrolled in Phase 2\/3 trial (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/biohaven-enrolls-first-patient-into-phase-23-trial-in-early-parkinsons-disease-targeting-neuroinflammation-with-novel-brain-penetrant-tyk2jak1-inhibitor-302467788.html\">May 2025<\/a>)<\/li>\n<li><strong>Strong analyst support<\/strong>: 13 analysts with &#8220;Strong Buy&#8221; rating, average target $54.62<\/li>\n<li><strong>Innovative pipeline<\/strong>: Multiple platforms including Kv7 modulation and TYK2\/JAK1 inhibition<\/li>\n<li><strong>Proven track record<\/strong>: Success with Nurtec ODT migraine treatment<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong>: Allocate no more than 3-5% of your portfolio to high-risk biotech stocks<\/li>\n<li><strong>Dollar-cost average<\/strong>: Buy in small increments over several months to reduce timing risk<\/li>\n<li><strong>Set price alerts<\/strong>: Monitor around November 11 earnings for potential entry points<\/li>\n<li><strong>Diversify<\/strong>: Balance with stable dividend stocks and index funds<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading BHVN is like watching clinical trials\u2014you need strong nerves and should never bet the house on Phase 1 results!&#8221;<\/p>\n<h2>\u2705 How to Buy Biohaven Ltd. (BHVN) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NYSE-listed stocks and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with an amount you&#8217;re comfortable potentially losing<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;BHVN&#8221;<\/td>\n<td>Use the exact ticker symbol for accurate results<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control entry price in volatile stocks<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission fees\u2014aim for less than 1% of trade value<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>Pocket Option makes stock investing accessible for beginners:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong>\u2014perfect for testing strategies with real money but minimal risk<\/li>\n<li><strong>Lightning-fast verification<\/strong>\u2014start trading with just one ID document in minutes<\/li>\n<li><strong>Diverse withdrawal options<\/strong>\u2014access your profits through multiple convenient methods<\/li>\n<li><strong>Educational resources<\/strong>\u2014learn while you trade with the comprehensive Pocket Option blog<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Biohaven in 2025: Neuroscience Innovation Leader<\/h2>\n<p>Biohaven dominates the neuroscience biotech space with one of the industry&#8217;s most innovative portfolios. Beyond their proven migraine treatments Nurtec ODT and Zavzpret, they&#8217;re pioneering breakthrough therapies for Parkinson&#8217;s, neuroinflammation, and rare neurological disorders. The company presented <strong>13 research abstracts<\/strong> at the 2025 American Academy of Neurology meeting, showcasing their scientific depth across multiple cutting-edge platforms including Kv7 modulation, extracellular protein degradation, and TRPM3 antagonism.<\/p>\n<p><strong>Interesting Fact<\/strong>: Biohaven&#8217;s Parkinson&#8217;s trial represents the first clinical study targeting neuroinflammation with a brain-penetrant TYK2\/JAK1 inhibitor\u2014a completely novel approach that could revolutionize treatment for over 10 million patients worldwide.<\/p>\n"},"faq":[{"question":"Is Biohaven a good long-term investment?","answer":"For risk-tolerant investors, yes. The company has multiple late-stage candidates and proven drug development capability, but biotech investing carries high risk of clinical failure."},{"question":"What's the biggest risk with BHVN stock?","answer":"Clinical trial failures\u2014approximately 90% of experimental drugs never reach market approval, which could significantly impact the stock price."},{"question":"How often does Biohaven report earnings?","answer":"Quarterly, with the next report scheduled for November 11, 2025. These events typically cause significant price volatility."},{"question":"Does Biohaven pay dividends?","answer":"No, as a clinical-stage biotech company, Biohaven reinvests all capital into research and development rather than paying dividends."},{"question":"What makes Biohaven different from other biotech companies?","answer":"Their proven track record with migraine drugs, diverse innovation platforms, and focus on neurological disorders with high unmet medical needs sets them apart in the competitive biotech landscape."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is Biohaven a good long-term investment?","answer":"For risk-tolerant investors, yes. The company has multiple late-stage candidates and proven drug development capability, but biotech investing carries high risk of clinical failure."},{"question":"What's the biggest risk with BHVN stock?","answer":"Clinical trial failures\u2014approximately 90% of experimental drugs never reach market approval, which could significantly impact the stock price."},{"question":"How often does Biohaven report earnings?","answer":"Quarterly, with the next report scheduled for November 11, 2025. These events typically cause significant price volatility."},{"question":"Does Biohaven pay dividends?","answer":"No, as a clinical-stage biotech company, Biohaven reinvests all capital into research and development rather than paying dividends."},{"question":"What makes Biohaven different from other biotech companies?","answer":"Their proven track record with migraine drugs, diverse innovation platforms, and focus on neurological disorders with high unmet medical needs sets them apart in the competitive biotech landscape."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Biohaven Ltd. (BHVN) shares - Investment in Biohaven Ltd. (BHVN) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Biohaven Ltd. (BHVN) shares - Investment in Biohaven Ltd. (BHVN) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T13:40:01+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Biohaven Ltd. (BHVN) shares &#8211; Investment in Biohaven Ltd. (BHVN) stock\",\"datePublished\":\"2025-08-24T13:40:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/\",\"name\":\"How to buy Biohaven Ltd. (BHVN) shares - Investment in Biohaven Ltd. (BHVN) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-24T13:40:01+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Biohaven Ltd. (BHVN) shares &#8211; Investment in Biohaven Ltd. (BHVN) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Biohaven Ltd. (BHVN) shares - Investment in Biohaven Ltd. (BHVN) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Biohaven Ltd. (BHVN) shares - Investment in Biohaven Ltd. (BHVN) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T13:40:01+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Biohaven Ltd. (BHVN) shares &#8211; Investment in Biohaven Ltd. (BHVN) stock","datePublished":"2025-08-24T13:40:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/","name":"How to buy Biohaven Ltd. (BHVN) shares - Investment in Biohaven Ltd. (BHVN) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-24T13:40:01+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biohaven\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Biohaven Ltd. (BHVN) shares &#8211; Investment in Biohaven Ltd. (BHVN) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":344670,"slug":"how-to-buy-biohaven","post_title":"Comment acheter des actions Biohaven Ltd. (BHVN) - Investir dans les actions Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-biohaven\/"},"it_IT":{"locale":"it_IT","id":344671,"slug":"how-to-buy-biohaven","post_title":"Come acquistare azioni Biohaven Ltd. (BHVN) - Investire in azioni Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-biohaven\/"},"pl_PL":{"locale":"pl_PL","id":344675,"slug":"how-to-buy-biohaven","post_title":"Jak kupi\u0107 akcje Biohaven Ltd. (BHVN) - Inwestycja w akcje Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-biohaven\/"},"es_ES":{"locale":"es_ES","id":344676,"slug":"how-to-buy-biohaven","post_title":"C\u00f3mo comprar acciones de Biohaven Ltd. (BHVN) - Inversi\u00f3n en acciones de Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-biohaven\/"},"th_TH":{"locale":"th_TH","id":344677,"slug":"how-to-buy-biohaven","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Biohaven Ltd. (BHVN) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-biohaven\/"},"tr_TR":{"locale":"tr_TR","id":344672,"slug":"how-to-buy-biohaven","post_title":"Biohaven Ltd. (BHVN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Biohaven Ltd. (BHVN) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biohaven\/"},"vt_VT":{"locale":"vt_VT","id":344674,"slug":"how-to-buy-biohaven","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Biohaven Ltd. (BHVN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biohaven\/"},"pt_AA":{"locale":"pt_AA","id":344673,"slug":"how-to-buy-biohaven","post_title":"Como comprar a\u00e7\u00f5es da Biohaven Ltd. (BHVN) - Investimento em a\u00e7\u00f5es da Biohaven Ltd. (BHVN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-biohaven\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/344658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=344658"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/344658\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=344658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=344658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=344658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}